Kegg Pathway: B cell receptor signaling pathway

KEGG ID: 04662

Reference Diagram

KEGG Diagram for B cell receptor signaling pathway

Rat

There are 62 IPI Records from this pathway found in Rattus norvegicus.

Location of B cell receptor signaling pathway proteins on Rat Genome

IPI Record Position
1: Akt1 6:137640482-137657552
2: Akt2 1:82686233-82726544
3: Akt3 13:92807672-92924984
4: Bcl10 2:243932330-244126396
5: Blnk 1:246091501-246165075
6: Btk X:121998935-122030289
7: Card11_predicted 12:14187395-14228930
8: Cd19 1:185501247-185507950
9: Cd22_predicted 1:85924354-85935805
10: Cd72 5:59918085-59925437
11: Cd79b 10:95703125-95706275
12: Cd81 1:203327287-203342901
13: Chp 3:106066389-106101638
14: Chuk_predicted 1:249122847-249157179
15: Cr2_predicted 13:111083495-111113610
16: Fcgr2b 13:86809006-86907701
17: Fos 6:109559154-109562546
18: Gsk3b 11:64284731-64428698
19: Hras 1:201385708-201388983
20: Ikbkb 16:73805082-73858088
21: Ikbkg X:160407166-160420190
22: Inpp5d 9:86576932-86679838
23: IPI00199940 1:80189446-80193462
24: Jun 5:115359397-115360401
25: Kras 4:182869242-182895106
26: Lyn 5:16933106-17054566
27: Malt1_predicted 18:61647647-61759718
28: Nfat5_predicted 19:37088893-37241536
29: Nfatc2_predicted 3:159654343-159773666
30: Nfatc3_predicted 19:35907874-35979801
31: Nfatc4 15:33969620-33978926
32: Nfkb1 2:233091020-233187501
33: Nfkb2 1:251521559-251527815
34: Nfkbia 6:75729302-75732474
35: Nfkbib 1:83865440-83873010
36: Nras 2:198292616-198302308
37: Pik3ca 2:118640277-118670170
38: Pik3cb 8:103886682-103957112
39: Pik3cd_predicted 5:166735338-166750186
40: Pik3cg_predicted 6:50444793-50477111
41: Pik3r1 2:32602673-32675350
42: Pik3r2 16:19171101-19179650
43: Pik3r3 5:136497494-136566473
44: Pirb 1:63651983-63659841
45: Plcg2 19:47875895-47947572
46: Ppp3ca 2:234333405-234408670
47: Ppp3cb 15:4003159-4022737
48: Ppp3cc 15:50616841-50666010
49: Ppp3r1 14:98047333-98131590
50: Ppp3r2 5:66423374-66424371
51: Prkcb1 1:181118102-181459480
52: Ptpn6 4:160843701-160856821
53: Rac1 12:11380314-11400531
54: Rac2 7:116520066-116532482
55: Rasgrp3_predicted 6:19812296-19845761
56: RGD1560225_predicted 18:77531419-77593552
57: RGD1563261_predicted 10:55182226-55247889
58: RGD1565941_predicted 2:204981254-205324562
59: Slc35b2 9:11044112-11050948
60: Syk 17:18443785-18483245
61: Vav1 :-
62: Vav2_predicted 3:6155687-6347206

Mouse

There are 62 IPI Records from this pathway found in Mus musculus.

Location of B cell receptor signaling pathway proteins on Mouse Genome

IPI Record Position
1: A2NTK6_MOUSE :-
2: Akt1 :-
3: Akt2 7:27300516-27348213
4: Akt3 1:178862039-178967772
5: Bcl10 3:145861736-145871669
6: Blnk 19:40982484-41025964
7: Btk X:129888686-129929418
8: Card11 5:141125799-141165891
9: Cd19 7:126199599-126205984
10: Cd22 7:30574589-30589029
11: Cd72 4:43468835-43475663
12: Cd79a 7:24606271-24610957
13: Cd79b 11:106127431-106130760
14: Cd81 7:142862185-142877314
15: Chuk 19:44126647-44160756
16: Cr2 1:196841897-196877439
17: Fcgr2b 1:172797236-172812709
18: Fos 12:86363004-86366372
19: Gsk3b 16:38008240-38165318
20: Hras1 7:141040427-141045314
21: Ifitm1 7:140819468-140821145
22: Ikbkb 8:24124758-24172108
23: Ikbkg X:70677332-70704240
24: Inpp5d 1:89451660-89549455
25: Jun 4:94542255-94544189
26: Kras 6:145173866-145207390
27: Lyn 4:3605272-3718759
28: Malt1 18:65556332-65604192
29: Nfat5 8:110182688-110268637
30: Nfatc1 18:80797750-80875130
31: Nfatc2 2:168167615-168292860
32: Nfatc3 8:108948972-109017574
33: Nfatc4 14:54779079-54788014
34: Nfkb1 3:135292997-135605172
35: Nfkb2 19:46358111-46365401
36: Nfkbia 12:56407731-56410725
37: Nfkbib 7:28467011-28475284
38: Nfkbie 17:45019297-45026752
39: Nras 3:103187290-103196967
40: Pik3ca 3:32627755-32654380
41: Pik3cb 9:98847754-98949439
42: Pik3cd 4:148492970-148542498
43: Pik3cg 12:32758720-32793858
44: Pik3r1 13:102781018-102868441
45: Pik3r2 8:73697168-73705691
46: Pik3r3 4:115719846-115800988
47: Pik3r5 11:68248320-68314041
48: Plcg2 8:120384268-120521119
49: Ppp3ca 3:136608220-136874773
50: Ppp3cb 14:19288592-19335096
51: Ppp3cc 14:68953164-69002587
52: Ppp3r1 :-
53: Ppp3r2 4:49699847-49703083
54: Prkcb1 7:122080445-122419803
55: Ptpn6 6:124686727-124698484
56: Rac1 5:143761100-143783654
57: Rac2 15:78386424-78400038
58: Rac3 11:120537558-120540059
59: Rasgrp3 17:75370673-75434118
60: Syk 13:52595933-52661224
61: Vav1 17:56964450-57013288
62: Vav2 2:27084113-27249042
63: Vav3 3:109468739-109813750

Human

There are 62 IPI Records from this pathway found in Homo sapiens.

Location of B cell receptor signaling pathway proteins on Human Genome

IPI Record Position
1: AKT1 14:104306734-104333125
2: AKT2 19:45430084-45483036
3: AKT3 1:241718158-242080053
4: BCL10 1:85504519-85516359
5: BLNK 10:97941453-98021316
6: BTK X:100491091-100527839
7: CARD11 7:2912309-3050025
8: CD19 16:28850779-28858164
9: CD22 19:40511944-40530098
10: CD72 9:35599981-35608753
11: CD79A 19:47073030-47077275
12: CD79B 17:59359832-59363446
13: CD81 11:2355096-2375225
14: CHP 15:39310729-39361369
15: CR2 1:205694198-205729863
16: FCGR2B 1:159899561-159915068
17: FOS 14:74815284-74818685
18: GSK3B 3:121028238-121295954
19: HRAS 11:522243-525572
20: IFITM1 11:303858-305272
21: IKBKB 8:42247986-42309130
22: IKBKG X:153423653-153446455
23: JUN 1:59019048-59022587
24: KRAS 12:25249449-25295121
25: LYN 8:56954926-57086493
26: MALT1 18:54489598-54568350
27: NFAT5 16:68156498-68296054
28: NFATC1 18:75256760-75390310
29: NFATC2 20:49441083-49592665
30: NFATC3 16:66676845-66818301
31: NFATC4 14:23907094-23918645
32: NFKB1 4:103641518-103757506
33: NFKB2 10:104144320-104152271
34: NFKBIA 14:34940475-34943703
35: NFKBIB 19:44082455-44091371
36: NFKBIE 6:44333881-44341503
37: NRAS 1:115048613-115102147
38: PIK3CA 3:180349005-180435189
39: PIK3CB 3:139856921-139960875
40: PIK3CD 1:9634390-9711564
41: PIK3CG 7:106292977-106334801
42: PIK3R1 5:67547360-67633403
43: PIK3R2 19:18125016-18142343
44: PIK3R3 1:46278399-46371054
45: PIK3R5 17:8722953-8756559
46: PLCG2 16:80370408-80549399
47: PPP3CA 4:102163610-102487376
48: PPP3CB 10:74866192-74925765
49: PPP3CC 8:22354541-22454580
50: PPP3R1 :-
51: PPP3R2 9:103393718-103397104
52: PRKCB1 16:23754823-24139358
53: PTPN6 12:6930763-6940740
54: RAC1 7:6380651-6410120
55: RAC2 22:35951238-35970241
56: RAC3 17:77582821-77585366
57: RASGRP3 2:33514920-33643162
58: SYK 9:92603890-92700652
59: VAV1 19:6723722-6808371
60: VAV2 9:135616837-135847547
61: VAV3 1:107915305-108309108

Google Scholar

Recent Literature

Negative regulation of lymphocyte development and function By the CBl family of proteins.

Bmed.org/fulltext.cgi?uids=18759930">Immunol Rev. 2008 Aug; 224(1): 229-38<Br>Huang F, Gu H

Negative regulation of intracellular signaling delivered By the antigen receptors and coreceptors plays an important role in lymphocyte development and activation. Recent data from our laBoratory and others have identified the CBl family of uBiquitin ligases as important negative regulators in Both T-cell and B-cell antigen receptor and coreceptor signaling. We show that c-CBl and CBl-B, two memBers of the CBl family of proteins, play a redundant role in estaBlishing the major histocompatiBility complex-dependent development of thymocytes and in thymic selection. They also control the activation threshold and CD28 costimulatory signaling in peripheral T cells. In B cells, c-CBl and CBl-B set the B-cell receptor signaling threshold critical for proper B-cell maturation and anergy induction. Biochemical studies indicate that the immune regulation By CBl proteins correlate with their uBiquitin ligase function. Inactivation of CBl-B also renders mice resistant to Both transplanted and spontaneous tumors due to an enhanced anti-tumor immunity of CD8(+) T cells. These findings thus place CBl proteins at the center of a complex immune network regulation and suggest that modulation of this signaling pathway may Be Beneficiary to the treatment of autoimmunity and cancer.

Altered B cell receptor signaling in human systemic lupus erythematosus.

Bmed.org/fulltext.cgi?uids=18723129">Autoimmun Rev. 2008 Aug 21; <Br>Jenks SA, Sanz I

Regulation of B cell receptor signaling is essential for the development of specific immunity while retaining tolerance to self. Systemic lupus erythematosus (SLE) is characterized By a loss of B cell tolerance and the production of anti-self antiBodies. Accompanying this Break down in tolerance are alterations in B cell receptor signal transduction including elevated induced calcium responses and increased protein phosphorylation. Specific pathways that negatively regulate B cell signaling have Been shown to Be impaired in some SLE patients. These patients have reduced levels of the kinase Lyn in lipid raft microdomains and this reduction is inversely correlated with increased CD45 in lipid rafts. Function and expression of the inhiBitory immunogloBulin receptor FcgammaRIIB is also reduced in Lupus IgM- CD27+ memory cells. Because the relative contriBution of different memory and transitional B cell suBsets can Be aBnormal in SLE patients, we Believe studies targeted to well defined B cell suBsets will Be necessary to further our understanding of signaling aBnormalities in SLE. Intracellular flow cytometric analysis of signaling is a useful approach to accomplish this goal.

Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial memBrane.

Bmed.org/fulltext.cgi?uids=18721452">Arthritis Res Ther. 2008 Aug 22; 10(4): R98<Br>HuBer R, Hummert C, Gausmann U, Pohlers D, Koczan D, Guthke R, Kinne RW

ABSTRACT: INTRODUCTION: Rheumatoid arthritis (RA) is a chronic inflammatory and destructive joint disease, characterized By overexpression of pro-inflammatory/-destructive genes and other activating genes (e.g., proto-oncogenes) in the synovial memBrane (SM). The gene expression in disease is often characterized By significant inter-individual variances via specific synchronization/ desynchronization of gene expression. To elucidate the contriBution of the variance to the pathogenesis of disease, expression variances were tested in SM samples of RA patients, osteoarthritis (OA) patients, and normal controls (NC). METHODS: Analysis of gene expression in RA, OA, and NC samples was carried out using Affymetrix U133A/B oligonucleotide arrays and the results were validated By real-time RT-PCR. For the comparison Between RA and NC, 568 genes with significantly different variances in the 2 groups (p < 0.05; Bonferroni/Holm corrected Brown-Forsythe version of the Levene test) were selected. For the comparison Between RA and OA, 333 genes were selected. Using the Kyoto encyclopedia of genes and genomes (KEGG), the pathways/complexes significantly affected By higher gene expression variances were identified in each group. RESULTS: 10 pathways/complexes significantly affected By higher gene expression variances were identified in RA compared to NC, including cytokine - cytokine receptor interactions, the TGF-Beta pathway, and anti-apoptosis. Compared to OA, 3 pathways with significantly higher variances were identified in RA (e.g., B cell receptor signaling, VEGF signaling). Functionally, the majority of the identified pathways is involved in the regulation of inflammation, proliferation, cell survival, and angiogenesis. CONCLUSIONS: In RA, a numBer of disease-relevant or even disease-specific pathways/complexes are characterized By Broad intra-group, inter-individual expression variances. Thus, RA pathogenesis in different individuals may depend to a lesser extent on common alterations of the expression of specific key genes, and rather on individual-specific alterations of different genes resulting in common disturBances of key pathways.

Immunomodulation of human B cells following treatment with intravenous immunogloBulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2.

Bmed.org/fulltext.cgi?uids=18689724">Int Immunol. 2008 Aug 8; <Br>Dussault N, Ducas E, Racine C, Jacques A, Paré I, Côté S, Néron S

In the treatment of autoimmune diseases, intravenous Igs (IVIg) are assumed to modulate immune cells through the Binding of surface receptors. IVIg act upon definite human B cell populations to modulate Ig repertoire, and such modulation might proceed through intracellular signaling. However, the heterogeneity of human B cell populations complicates investigations of the intracellular pathways involved in IVIg-induced B cell modulation. The aim of this study was to estaBlish a model allowing the screening of IVIg signal transduction in human B cell lines and to attempt transposing oBservations made in cell lines to normal human B lymphocytes. Nine human B cell lines were treated with IVIg with the goal of selecting the most suitaBle model for human B lymphocytes. The IgG(+) DB cell line, whose response was similar to that of human B lymphocytes, showed reduced IVIg modulation following addition of PD98059, an inhiBitor of extracellular signal-regulated protein kinase 1/2 (ERK1/2). The IVIg-induced ERK1/2 phosphorylation was indeed proportional to the dosage of monomeric IVIg used when tested on DB cells as well as Pfeiffer cells, another IgG(+) cell line. In addition, two other intermediates, GrB2-associated Binder 1 (GaB1) and Akt, showed increased phosphorylation in IVIg-treated DB cells. IVIg induction of ERK1/2 phosphorylation was finally oBserved in peripheral human B lymphocytes, specifically within the IgG(+) B cell population. In conclusion, IVIg immunomodulation of human B cells can thus Be linked to intracellular transduction pathways involving the phosphorylation of ERK1/2, which in comBination with GaB1 and Akt, may Be related to B cell antigen receptor signaling.

MemBrane heterogeneities in the formation of B cell receptor-Lyn kinase microclusters and the immune synapse.

Bmed.org/fulltext.cgi?uids=18644892">J cell Biol. 2008 Jul 28; 182(2): 367-79<Br>Sohn HW, Tolar P, Pierce SK

Antigen Binding to the B cell receptors (BCRs) induces BCR clustering, phosphorylation of BCRs By the Src family kinase Lyn, initiation of signaling, and formation of an immune synapse. We investigated B cells as they first encountered antigen on a memBrane using live cell high resolution total internal reflection fluorescence microscopy in conjunction with fluorescence resonance energy transfer. Newly formed BCR microclusters perturB the local memBrane microenvironment, leading to association with a lipid raft proBe. This early event is BCR intrinsic and independent of BCR signaling. Association of BCR microclusters with memBrane-tethered Lyn depends on Lyn activity and persists as microclusters accumulate and form an immune synapse. MemBrane perturBation and BCR-Lyn association correlate Both temporally and spatially with the transition of microclustered BCRs from a "closed" to an "open" active signaling conformation. Visualization and analysis of the earliest events in BCR signaling highlight the importance of the memBrane microenvironment for formation of BCR-Lyn complexes and the B cell immune synapse.

The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice.

Bmed.org/fulltext.cgi?uids=18641300">J Immunol. 2008 Aug 1; 181(3): 1644-54<Br>Zhang XK, Moussa O, LaRue A, Bradshaw S, Molano I, Spyropoulos DD, Gilkeson GS, Watson DK

Fli-1 Belongs to the Ets transcription factor family and is expressed primarily in hematopoietic cells, including most cells active in immunity. To assess the role of Fli-1 in lymphocyte development in vivo, we generated mice that express a truncated Fli-1 protein, lacking the C-terminal transcriptional activation domain (Fli-1(DeltaCTA)). Fli-1(DeltaCTA)/Fli-1(DeltaCTA) mice had significantly fewer splenic follicular B cells, and an increased numBer of transitional and marginal zone B cells, compared with wild-type controls. Bone marrow reconstitution studies demonstrated that this phenotype is the result of lymphocyte intrinsic effects. Expression of Igalpha and other genes implicated in B cell development, including Pax-5, E2A, and Egr-1, are reduced, while Id1 and Id2 are increased in Fli-1(DeltaCTA)/Fli-1(DeltaCTA) mice. Proliferation of B cells from Fli-1(DeltaCTA)/Fli-1(DeltaCTA) mice was diminished, although intracellular Ca(2+) flux in B cells from Fli-1(DeltaCTA)/Fli-1(DeltaCTA) mice was similar to that of wild-type controls after anti-IgM stimulation. Immune responses and in vitro class switch recomBination were also altered in Fli-1(DeltaCTA)/Fli-1(DeltaCTA) mice. Thus, Fli-1 modulates B cell development Both centrally and peripherally, resulting in a significant impact on the in vivo immune response.

Induction of autophagy By B cell antigen receptor stimulation and its inhiBition By costimulation.

Bmed.org/fulltext.cgi?uids=18625201">Biochem Biophys Res Commun. 2008 Sep 19; 374(2): 274-81<Br>WatanaBe K, Ichinose S, Hayashizaki K, TsuBata T

Autophagy is a major pathway for degradation of cytoplasmic components, and is induced By some apoptotic stimuli mostly in cancer cells under the condition in which apoptosis is Blocked. Ligation of the B cell antigen receptor (BCR) induces apoptosis and plays a crucial role in self-tolerance. However, whether BCR ligation induces autophagy is not clear. Here, we demonstrate that autophagosomes are extensively formed in normal mouse B cells as well as the WEHI-231 B cell line upon induction of BCR ligation-induced apoptosis regardless of whether apoptosis is Blocked By overexpression of Bcl-2. In contrast, autophagosomes were not formed during apoptosis of spleen B cells cultured with medium alone or in BCR-ligated BAL17 cells which do not undergo apoptosis. Moreover, autophagy is not induced when apoptotic BCR signaling is aBrogated By CD40 signaling. These results indicate that autophagy is induced specifically By apoptotic BCR signaling even in unmanipulated normal B cells.

Epstein-Barr virus latent memBrane protein 2A preferentially signals through the Src family kinase Lyn.

Bmed.org/fulltext.cgi?uids=18579586">J Virol. 2008 Sep; 82(17): 8520-8<Br>Rovedo M, Longnecker R

Latent memBrane protein 2A (LMP2A) is a viral protein expressed during Epstein-Barr virus (EBV) latency in EBV-infected B cells Both in cell culture and in vivo. LMP2A has important roles in modulating B-cell receptor signal transduction and provides survival and developmental signals to B cells in vivo. Although Lyn has Been shown to Be important in mediating LMP2A signaling, it is still unclear if Lyn is used preferentially or if LMP2A associates promiscuously with other Src family kinase (SFK) memBers. To investigate the role of various SFKs in LMP2A signaling, we crossed LMP2A transgenic mice (TgE) with Lyn(-/-), Fyn(-/-), or Blk(-/-) mice. TgE Lyn(-/-) mice had a larger immunogloBulin M (IgM)-positive B-cell population than TgE mice, suggesting that the aBsence of Lyn prevents LMP2A from delivering survival and developmental signals to the B cells. Both TgE Fyn(-/-) and TgE Blk(-/-) mice have an IgM-negative population of splenic B cells, similar to the TgE mice. LMP2A was also transiently transfected into the human EBV-negative B-cell line BJAB to determine